Conversely, when GPX8 is silenced, the histamine-induced release of Ca 2+ from the endoplasmic reticulum to mitochondria and cytoplasm is increased (Yoboue et al., 2017)
In the Diabetes & Metabolic Syndrome: Clinical Research & Reviews study, risk of serious adverse gastrointestinal events was high following semaglutide treatment compared to the placebo group
The effects of L-carnitine supplementation on performance during interval swimming
You can read the abstract of this article at LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept A novel dual GIP and GLP-1 receptor agonist, LY3298176, was developed to determine whether the metabolic action of GIP adds to the established clinical benefits of selective GLP-1 receptor agonists in type 2 diabetes mellitus (T2DM)
Tirzepatide is a dual agonist of GLP-1R and GIP (gastric inhibitory polypeptide) receptors, showing promising results in improving glycemic control and promoting weight loss